⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 5, 2014Clinical Nuclear Medicine

Brain PET in the Diagnosis of Alzheimer’s Disease

View Full Paper

Ask AI

Bookmark

Share

Abstract

FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marcus et al. (2014) studied this question.

synapsesocial.com/papers/69da1a500d540cafc5838592 https://doi.org/10.1097/rlu.0000000000000547

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmationRetrospective Study · 2001 · 565 citations
2Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapyPrognostic Study · 2012 · 79 citations
3Molecular Imaging of Alzheimer Disease PathologyOriginal Research · 2014 · 23 citations
4Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other DementiasDiagnostic Study · 2008 · 733 citations
5In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18 F-AV-45 (Flobetapir F 18)Case-Control Study · 2010 · 683 citations